Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Pulmonary Pharmacology & Therapeutics|October 23, 2019
Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysisLuigino Calzetta, Fabiano Di Marco, Francesco Blasi, et al.
Multidisciplinary Respiratory Medicine|February 7, 2022
Multidisciplinary management of type 2 inflammatory diseasesGianenrico Senna, Claudio Micheletto, Giorgio Piacentini, et al.
Thoracic Cancer|January 27, 2025
Postoperative Lung Function Advantages in Pulmonary Segmentectomy for Early-Stage Lung CancerErnesto Crisafulli, Claudio Micheletto, Alessio Campisi, et al.
Current Medical Research and Opinion|August 30, 2024
Perception and knowledge of general practitioners on COPD management according to the GOLD23 document and reimbursement criteria for drugs prescription: an e-Delphi studyEttore Marconi, Francesco Paolo Lombardo, Claudio Micheletto, et al.
Respiratory Medicine|April 15, 2024
Development and validation of a prediction score to assess the risk of incurring in COPD-related exacerbations: a population-based study in primary careFrancesco Lapi, Ettore Marconi, Francesco Paolo Lombardo, et al.
ERJ Open Research|May 5, 2020
Low adherence to inhaled corticosteroids/long-acting β<sub>2</sub>-agonists and biologic treatment in severe asthmaticsMarco Caminati, Andrea Vianello, Margherita Andretta, et al.
Expert Opinion on Biological Therapy|January 10, 2024
Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidenceMarco Caminati, Claudio Micheletto, Francesca Norelli, et al.
Internal and Emergency Medicine|September 15, 2021
Lung cancer and interstitial lung diseases: the lack of prognostic impact of lung cancer in IPFLoredana Carobene, Donatella Spina, Maria Giulia Disanto, et al.
Orphanet Journal of Rare Diseases|September 26, 2023
Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenanceMarco Caminati, Matteo Maule, Roberto Benoni, et al.
Human Vaccines & Immunotherapeutics|September 3, 2025
Awareness of respiratory syncytial virus and other respiratory disease vaccines among healthcare professionals and their patients in Italy: Insights from a literature review and a web-based surveyClaudio Micheletto, Giancarlo Lorenzini, Sara De Grazia, et al.
Pageof 8